To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004

NCT07245251 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphobkastic Leukemia

Interventions

DRUG: STR-P004

Sponsor

Starna Therapeutics